Loading company…
Riskpilot
← Back to search
Sign in
Get full access
NORSK MUSKELTERAPI AS
AS
Active
Org 923603867
Stieveien 182, 4760 Birkeland
Other education n.e.c. · NACE 8559
Est. 2019
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 812K
+1% vs 2024
EBITDA margin
-4.3%
-136% vs 2024
Equity ratio
-53.8%
Financial strength
Net profit 2025
NOK -35K
-137% vs 2024
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
NOK 812K
+1%
EBITDA
NOK -35K
-136%
Net profit
NOK -35K
-137%
Total assets
NOK 71K
-3%
Equity
NOK -38K
-1056%
Employees
1
—
Company information
Legal name
NORSK MUSKELTERAPI AS
Org number
923603867
Legal form
Aksjeselskap
NACE code
8559 · Other education n.e.c.
Founded
14. oktober 2019
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Å tilby terapeutisk behandling. Drive skole, kurs og undervisningsvirksomhet innen terapeutisk behandling og hva der står i forbindelse hermed.
Contact
Address
Stieveien 182, 4760 Birkeland
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Other education n.e.c.
Companies in Birkenes
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2021
1M
2022
1M
2023
1M
2024
1M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
NOK thousands
Item
2021
2022
2023
2024
2025
Revenue
494
595
743
807
812
Staff expenses
−43
−0
−0
−0
−19
EBITDA
9
−120
11
97
−35
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
9
−120
11
97
−35
Net financials
0
0
0
−2
0
Profit before tax
9
−120
11
95
−35
Tax
−0
−0
−0
−0
−0
Net profit
9
−120
11
95
−35
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
2025
Total assets
35
46
36
74
71
Equity
11
−110
−98
−3
−38
Long-term debt
0
0
0
0
0
Short-term debt
24
156
134
77
110
Total debt
24
156
134
77
110
Financial ratios
5-year trend
EBITDA margin
-4.3%
This company
15.8%
Market median
-127% vs market
2021
2025
Equity ratio
-53.8%
This company
38.2%
Market median
-241% vs market
2021
2025
Return on equity
-3512600.0%
This company
18.4%
Market median
-19090317% vs market
2021
2025
Net profit margin
-4.3%
This company
8.1%
Market median
-153% vs market
2021
2025
Asset turnover
11.37×
This company
1.12×
Market median
+915% vs market
2021
2025
Debt / equity
2.86×
This company
0.62×
Market median
-361% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
PD
Per Daniel Hellqvist
Chief Executive Officer
Chief Executive Officer
2019
JM
Jørn Magne Johannessen
Deputy Member
Deputy Member
2019
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of NORSK MUSKELTERAPI AS also hold positions in
0
other companies.
Person
Role here
Other companies
Per Daniel Hellqvist
Chief Executive Officer
0 companies
Jørn Magne Johannessen
Deputy Member
0 companies